Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non-small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102)
Eur J Cancer. 2025 Sep 12;229:115779. doi: 10.1016/j.ejca.2025.115779. Online ahead of print. ABSTRACT BACKGROUND: Individuals with thyroid transcription factor-1 (TTF-1)-negative […]

